126: The Billion-Dollar Race to Defy Aging – David Dror on Longevity Investment

In this episode of Longevity Junky, Buck Joffrey and Nikki Leigh sit down with David Mark Dror, author of Investors in Longevity, to explore the multi-billion-dollar investments driving longevity breakthroughs. Discover how Jeff Bezos, Peter Thiel, and major biotech firms are funding research in:

- Gene therapy and cellular reprogramming to slow aging

- AI-driven drug discovery for life extension

- Regenerative medicine and stem cell therapy

Plus, we answer a listener’s burning question: What essential lab tests should you get for optimal health—ones most doctors don’t order?

If you're curious about how the biggest names in tech and biotech are investing in longevity—and what it means for the future of healthcare, wealth, and aging—this episode is a must-listen!

Learn more about David Dror: https://www.linkedin.com/in/daviddror/

Bioxcellerator is offering our listeners special discounts and offers on stem cell therapy. If you are interested, please reach out to Liz at [email protected].

Questions? Send us a message at:

www.longevityjunky.com

Follow us on social media:

Instagram: https://www.instagram.com/longevityjunkypodcast

Facebook: https://www.facebook.com/profile.php?id=61564965475593

Twitter: https://x.com/longevity_junky

Tiktok: https://www.tiktok.com/@longevityjunkypodcast

Hosted on Acast. See acast.com/privacy for more information.